Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KB-1163

1G4V2-hIgG1

Home » 1G4V2-hIgG1

Background of 1G4V2-hIgG1

The lymphocyte antigen 6 complex locus G6D (LY6G6D) is a member of the lymphocyte antigen 6 superfamily (Ly-6SF). LY6G6D is positioned within the MHC class III region on chromosome 6, wherein it encodes a polypeptide comprising 133 amino acid residues with an approximate molecular weight of 13.7 kDa. Genentech, an innovative leader in large molecule pharmaceuticals, has developed a anti-LY6G6D/CD3 bispecific antibody (LY6G6D-TDB) for colorectal cancer (CRC) treatment in its earlier days. In mouse xenograft tumor models, LY6G6D-TDB shows anti-tumor efficacy as a single agent against established colorectal tumors. 1G4V1-hIgG1 is a monoclonal antibody that only binds to LY6G6D.

Specifications

Catalog Number:
KB-1163
Antibody Name:
1G4V2-hIgG1
Isotype:
Human IgG1,kappa
FC Muations:
Wild Type
Target:
LY6G6D
Species Reactivity:
Human
Host Cell Line:
EXPI CHO
Purification Method:
Affinity purified
Concentration:
>2 mg/mL
Formulation:
50 mM sodium citrate,150mM NaCl,pH5.5
Purity:
>95% by SDS-PAGE and SEC-HPLC
Validation:
ELISA
Endotoxin Level:
<0.2 EU/mg as determined by the LAL method
Sterility:
0.2μm filtered
Storage:
It is recommended that the protein should be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Stability:
Stable for twelve months from date of receipt when stored at -20°C to -80°C; Stored at 2-8°C for one month without detectable loss of activity.

Characterization

Application

References

  1. Novel Anti-LY6G6D/CD3 T-Cell–Dependent Bispecific Antibody for the Treatment of Colorectal Cancer